摘要
目的分析阿奇霉素联和妇康健合剂治疗支原体属感染性盆腔炎对患者子宫血流动力学指标的影响,以期探寻最佳的治疗支原体属感染性盆腔炎患者的方案。方法选取医院2012年7月-2015年6月收治的400例支原体属感染性盆腔炎患者为研究对象,随机分为治疗组与对照组,两组各200例;治疗组患者接受阿奇霉素和妇康健合剂的联用治疗;对照组患者单纯应用阿奇霉素,对比两组患者的临床疗效。结果治疗组血流速度(Vmin)指标数值为(0.55±0.02)cm/s,搏动指数为2.35±0.14,阻力指数为0.87±0.02;对照组Vmin指标数值为(0.44±0.03)cm/s、搏动指数为2.11±0.13、阻力指数为0.78±0.04,治疗组在子宫血流动力学指标的数值比较远高于对照组患者,两组比较差异有统计学意义(P<0.05)。结论阿奇霉素联合妇康健合剂治疗支原体属感染性盆腔炎相比单用阿奇霉素的治疗效果更理想,预后效果较好。
OBJECTIVE To observe the impact of azithromycin combined with woman′s health agent on uterine hemodynamics of patients with Mycoplasmapelvic inflammatory disease so as to seek the optimal treatment program for the patients with Mycoplasma pelvic inflammatory disease.METHODS A total of 400 patients with Mycoplasma pelvic inflammatory disease who were treated in the hospital from Jul 2012 to Jun 2015 were recruited as the study objects and randomly divided into the treatment group and the control group,with 200 cases in each.The treatment group was treated with azitromycin combined with woman′s health agent,while the control group was treated with single azithromycin;the clinical effects were observed and compared between the two groups of patients.RESULTS The blood flow velocity（Vmin）index value of the treatment group was（0.55±0.02）cm/s,the control group（0.44±0.03）cm/s;the pulsatility index of the treatment group was 2.35±0.14,the control group2.11±0.13;the resistance index of the treatment group was 0.87±0.02,the control grouP〈0.78±0.04;the values of the uterine hemodynamic indexes of the treatment group were significantly higher than those of the control group（P〈0.05）.CONCLUSION Azithromycin combined with woman′s health agent can achieve more significant effect on treatment of the Mycoplasma pelvic inflammatory disease than single azithromycin,with the prognosis favorable.
出处
《中华医院感染学杂志》
CAS
CSCD
北大核心
2016年第1期167-168,171,共3页
Chinese Journal of Nosocomiology
基金
湖北省医学科研基金资助项目(A2013621)
湖北省恩施州第二批农业与社会发展科技指导性计划基金资助项目[恩州科业(2013)15-23]
关键词
阿奇霉素
妇康健合剂
支原体属
盆腔炎
子宫血流动力学指标
Azithromycin
Woman′s health agent
Mycoplasma
Pelvic inflammatory disease
Uterine hemody namic index
